ARCHITECT Galectin-3 test regulatory update

By WIR Staff | Apr 1, 2013 | 7:00 AM GMT

BG Medicine disclosed in its 2012 earnings that partner Fujirebio Inc. (Tokyo, Japan) withdrew a 510(k) application for the ARCHITECT